The product registration in the rest of the World is a challenging task because the regions
under it are not harmonized. CIS and Latin American regions come under semi-regulated
market. These regions have somewhat harmonized their regulatory organization. The significance
of an emerging market is increasing globally. It is important for pharmaceutical companies to be
up-to-date with the latest regulatory development. Both the regions follow their regional checklist
for Drug Product Registration. Latin America includes a group of countries like Brazil, Guatemala
and Peru etc, whereas CIS includes Russia, Ukraine, Uzbekistan, Armenia and Tajikistan etc.